Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 964

1.

Regulatory mechanisms of ryanodine receptor/Ca2+ release channel revealed by recent advancements in structural studies.

Ogawa H, Kurebayashi N, Yamazawa T, Murayama T.

J Muscle Res Cell Motil. 2020 Feb 10. doi: 10.1007/s10974-020-09575-6. [Epub ahead of print]

PMID:
32040690
2.

Protocol For An Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Safety Study.

Nomura A, Terashima T, Mizukoshi E, Kitahara M, Murayama T, Kaneko S.

JMIR Res Protoc. 2020 Feb 10;9(2):e17082. doi: 10.2196/17082.

3.

Measuring Lipid Transfer Protein Activity Using Bicelle-Dilution Model Membranes.

Gao YG, My Le LT, Zhai X, Boldyrev IA, Mishra SK, Tischer A, Murayama T, Nishida A, Molotkovsky JG, Alam A, Brown RE.

Anal Chem. 2020 Feb 18;92(4):3417-3425. doi: 10.1021/acs.analchem.9b05523. Epub 2020 Feb 4.

PMID:
31970977
4.

Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.

Nozaki Y, Kato Y, Uike K, Yamamura K, Kikuchi M, Yasuda M, Ohno S, Horie M, Murayama T, Kurebayashi N, Horigome H.

Circ J. 2020 Jan 24;84(2):226-234. doi: 10.1253/circj.CJ-19-0720. Epub 2019 Dec 26.

5.

Ring-Opened Hemiporphyrazines: Helical Molecules Exhibiting Circularly Polarized Luminescence.

Tanaka Y, Murayama T, Muranaka A, Imai E, Uchiyama M.

Chemistry. 2020 Feb 6;26(8):1768-1771. doi: 10.1002/chem.201905246. Epub 2020 Jan 30.

PMID:
31868264
6.

Insights into channel modulation mechanism of RYR1 mutants using Ca2+ imaging and molecular dynamics.

Yamazawa T, Ogawa H, Murayama T, Yamaguchi M, Oyamada H, Suzuki J, Kurebayashi N, Kanemaru K, Oguchi K, Sakurai T, Iino M.

J Gen Physiol. 2020 Jan 6;152(1). pii: e201812235. doi: 10.1085/jgp.201812235.

PMID:
31841587
7.

[Systemic mastocytosis with refractory ascites successfully treated with interferon-α and a leukotriene receptor antagonist].

Mizuno I, Tominaga R, Gomyo H, Maeda A, Kajimoto K, Yonezawa K, Shinzato I, Murayama T.

Rinsho Ketsueki. 2019;60(11):1555-1559. doi: 10.11406/rinketsu.60.1555. Japanese.

PMID:
31839634
8.

Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases.

Murayama T, Kurebayashi N.

Curr Protoc Pharmacol. 2019 Dec;87(1):e71. doi: 10.1002/cpph.71.

PMID:
31834676
9.

Importance of Size and Contact Structure of Gold Nanoparticles for the Genesis of Unique Catalytic Processes.

Ishida T, Murayama T, Taketoshi A, Haruta M.

Chem Rev. 2020 Jan 22;120(2):464-525. doi: 10.1021/acs.chemrev.9b00551. Epub 2019 Dec 10.

PMID:
31820953
10.

TRIC-A Channel Maintains Store Calcium Handling by Interacting with Type 2 Ryanodine Receptor in Cardiac Muscle.

Zhou X, Park KH, Yamazaki D, Lin PH, Nishi M, Ma Z, Qiu L, Murayama T, Zou X, Takeshima H, Zhou J, Ma J.

Circ Res. 2019 Dec 6. doi: 10.1161/CIRCRESAHA.119.316241. [Epub ahead of print]

PMID:
31805819
11.

Higher estimated net endogenous acid production with lower intake of fruits and vegetables based on a dietary survey is associated with the progression of chronic kidney disease.

Toba K, Hosojima M, Kabasawa H, Kuwahara S, Murayama T, Yamamoto-Kabasawa K, Kaseda R, Wada E, Watanabe R, Tanabe N, Suzuki Y, Narita I, Saito A.

BMC Nephrol. 2019 Nov 21;20(1):421. doi: 10.1186/s12882-019-1591-8.

12.

Effect of microslit retention on the bond strength of zirconia to dental materials.

Iwaguro S, Shimoe S, Hirata I, Murayama T, Satoda T.

Dent Mater J. 2019 Dec 1;38(6):1043-1052. doi: 10.4012/dmj.2018-351. Epub 2019 Oct 2.

13.

Applying deep artificial neural network approach to maxillofacial prostheses coloration.

Mine Y, Suzuki S, Eguchi T, Murayama T.

J Prosthodont Res. 2019 Sep 22. pii: S1883-1958(19)30326-3. doi: 10.1016/j.jpor.2019.08.006. [Epub ahead of print]

PMID:
31554602
14.

Accumulation of sphingomyelin in Niemann-Pick disease type C cells disrupts Rab9-dependent vesicular trafficking of cholesterol.

Wanikawa M, Nakamura H, Emori S, Hashimoto N, Murayama T.

J Cell Physiol. 2020 Mar;235(3):2300-2309. doi: 10.1002/jcp.29137. Epub 2019 Sep 6.

PMID:
31489965
15.

Longitudinal observation of ten family members with idiopathic basal ganglia calcification: A case report.

Kobayashi S, Utsumi K, Tateno M, Iwamoto T, Murayama T, Sohma H, Ukai W, Hashimoto E, Kawanishi C.

World J Clin Cases. 2019 Jun 26;7(12):1483-1491. doi: 10.12998/wjcc.v7.i12.1483.

16.

Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay.

Mori S, Iinuma H, Manaka N, Ishigami-Yuasa M, Murayama T, Nishijima Y, Sakurai A, Arai R, Kurebayashi N, Sakurai T, Kagechika H.

Eur J Med Chem. 2019 Oct 1;179:837-848. doi: 10.1016/j.ejmech.2019.06.076. Epub 2019 Jun 29.

PMID:
31299492
17.

A herbivore-induced homoterpene volatile is emitted from Basella alba leaves.

Aboshi T, Toda A, Ashitani T, Murayama T.

Biosci Biotechnol Biochem. 2019 Nov;83(11):1989-1991. doi: 10.1080/09168451.2019.1637714. Epub 2019 Jul 6.

PMID:
31280680
18.

An influenza-derived membrane tension-modulating peptide regulates cell movement and morphology via actin remodeling.

Masuda T, Baba K, Nomura T, Tsujita K, Murayama T, Itoh T, Takatani-Nakase T, Sokabe M, Inagaki N, Futaki S.

Commun Biol. 2019 Jun 26;2:243. doi: 10.1038/s42003-019-0486-3. eCollection 2019.

19.

Patient-Derived Xenograft Models of Breast Cancer and Their Application.

Murayama T, Gotoh N.

Cells. 2019 Jun 20;8(6). pii: E621. doi: 10.3390/cells8060621. Review.

20.

A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.

Wakabayashi H, Inaki A, Yoshimura K, Murayama T, Imai Y, Higuchi T, Jinguji M, Shiga T, Kinuya S.

Sci Rep. 2019 May 20;9(1):7625. doi: 10.1038/s41598-019-43880-6.

21.

Concepts and techniques: how to determine and identify the appropriate target segment in anatomical pulmonary segmentectomy?

Sato M, Murayama T, Nakajima J.

J Thorac Dis. 2019 Mar;11(3):972-986. doi: 10.21037/jtd.2019.02.83. Review.

22.

Redox-Active Zeolitic Transition Metal Oxides Based on ε-Keggin Units for Selective Oxidation.

Zhang Z, Ishikawa S, Zhu Q, Murayama T, Sadakane M, Hara M, Ueda W.

Inorg Chem. 2019 May 6;58(9):6283-6293. doi: 10.1021/acs.inorgchem.9b00502. Epub 2019 Apr 23.

PMID:
31013070
23.

Fatigue resistance of yttria-stabilized tetragonal zirconia polycrystal clasps for removable partial dentures.

Peng TY, Shimoe S, Tanoue N, Akebono H, Murayama T, Satoda T.

Eur J Oral Sci. 2019 Jun;127(3):269-275. doi: 10.1111/eos.12615. Epub 2019 Apr 19.

PMID:
31002752
24.

Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cells.

Kurata N, Tokashiki N, Fukushima K, Misao T, Hasuoka N, Kitagawa K, Mashimo M, Regan JW, Murayama T, Fujino H.

Eur J Pharmacol. 2019 Jun 15;853:308-315. doi: 10.1016/j.ejphar.2019.04.014. Epub 2019 Apr 10.

PMID:
30980797
25.

The AMAGAMI technique: an easy technique to achieve precise stapling in thoracoscopic segmentectomy.

Sato M, Murayama T, Nakajima J.

J Thorac Dis. 2019 Jan;11(1):276-279. doi: 10.21037/jtd.2018.12.89.

26.

Active propagation of dendritic electrical signals in C. elegans.

Shindou T, Ochi-Shindou M, Murayama T, Saita EI, Momohara Y, Wickens JR, Maruyama IN.

Sci Rep. 2019 Mar 5;9(1):3430. doi: 10.1038/s41598-019-40158-9.

27.

Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells.

Sakai Y, Honda M, Matsui S, Komori O, Murayama T, Fujiwara T, Mizuno M, Imai Y, Yoshimura K, Nasti A, Wada T, Iida N, Kitahara M, Horii R, Toshikatsu T, Nishikawa M, Okafuji H, Mizukoshi E, Yamashita T, Yamashita T, Arai K, Kitamura K, Kawaguchi K, Takatori H, Shimakami T, Terashima T, Hayashi T, Nio K, Kaneko S; Hokuriku Liver Study Group.

Cancer Sci. 2019 Apr;110(4):1364-1388. doi: 10.1111/cas.13971. Epub 2019 Mar 27. Erratum in: Cancer Sci. 2019 Nov;110(11):3615.

28.

Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H.

BMC Musculoskelet Disord. 2019 Feb 9;20(1):68. doi: 10.1186/s12891-019-2453-z.

29.

Effects of intravesicular loading of a Ca2+ chelator and depolymerization of actin fibers on neurotransmitter release in frog motor nerve terminals.

Narita K, Suzuki N, Himi N, Murayama T, Nakagawa T, Okabe N, Nakamura-Maruyama E, Hayashi N, Sakamoto I, Miyamoto O, Kuba K.

Eur J Neurosci. 2019 Jul;50(1):1700-1711. doi: 10.1111/ejn.14353. Epub 2019 Feb 8.

PMID:
30687962
30.

Conversion of Ca2+ oscillation into propagative electrical signals by Ca2+-activated ion channels and connexin as a reconstituted Ca2+ clock model for the pacemaker activity.

Saeki T, Kimura T, Hashidume K, Murayama T, Yamamura H, Ohya S, Suzuki Y, Nakayama S, Imaizumi Y.

Biochem Biophys Res Commun. 2019 Mar 5;510(2):242-247. doi: 10.1016/j.bbrc.2019.01.080. Epub 2019 Jan 24.

PMID:
30686532
31.

Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.

Tominaga K, Minato H, Murayama T, Sasahara A, Nishimura T, Kiyokawa E, Kanauchi H, Shimizu S, Sato A, Nishioka K, Tsuji EI, Yano M, Ogawa T, Ishii H, Mori M, Akashi K, Okamoto K, Tanabe M, Tada KI, Tojo A, Gotoh N.

Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):625-630. doi: 10.1073/pnas.1806851116. Epub 2018 Dec 26.

32.

Age at the time of hip fracture in patients with rheumatoid arthritis is 4 years greater than it was 10 years before, but is still younger than that of the general population.

Arai K, Suzuki N, Murayama T, Kondo N, Otsuka H, Koizumi M, Hosaka N, Fujikawa R, Yanabashi K, Sasage Y, Yoshida K, Kimura K, Higuchi K, Ajiro J, Endo N.

Mod Rheumatol. 2020 Jan;30(1):64-69. doi: 10.1080/14397595.2018.1561351. Epub 2019 Jan 22.

PMID:
30572779
33.

Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.

Nishimura T, Nakata A, Chen X, Nishi K, Meguro-Horike M, Sasaki S, Kita K, Horike SI, Saitoh K, Kato K, Igarashi K, Murayama T, Kohno S, Takahashi C, Mukaida N, Yano S, Soga T, Tojo A, Gotoh N.

Oncogene. 2019 Apr;38(14):2464-2481. doi: 10.1038/s41388-018-0589-1. Epub 2018 Dec 7.

34.

Cellular density-dependent increases in HIF-1α compete with c-Myc to down-regulate human EP4 receptor promoter activity through Sp-1-binding region.

Seira N, Yamagata K, Fukushima K, Araki Y, Kurata N, Yanagisawa N, Mashimo M, Nakamura H, Regan JW, Murayama T, Fujino H.

Pharmacol Res Perspect. 2018 Nov 11;6(6):e00441. doi: 10.1002/prp2.441. eCollection 2018 Dec.

35.

Phosphorylation and inhibition of ceramide kinase by protein kinase C-β: Their changes by serine residue mutations.

Takahashi H, Ashikawa H, Nakamura H, Murayama T.

Cell Signal. 2019 Feb;54:59-68. doi: 10.1016/j.cellsig.2018.11.008. Epub 2018 Nov 15.

PMID:
30448345
36.

Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate.

Nishino S, Yamashita H, Tamori M, Mashimo M, Yamagata K, Nakamura H, Murayama T.

J Cell Biochem. 2019 Apr;120(4):5396-5408. doi: 10.1002/jcb.27818. Epub 2018 Nov 15.

PMID:
30444039
37.

Dysfunction of muscle contraction with impaired intracellular Ca2+ handling in skeletal muscle and the effect of exercise training in male db/db mice.

Eshima H, Tamura Y, Kakehi S, Nakamura K, Kurebayashi N, Murayama T, Kakigi R, Sakurai T, Kawamori R, Watada H.

J Appl Physiol (1985). 2019 Jan 1;126(1):170-182. doi: 10.1152/japplphysiol.00048.2018. Epub 2018 Nov 15.

38.

Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Inui Y, Yakushijin K, Okamura A, Tanaka Y, Shinzato I, Nomura T, Ichikawa H, Mizutani Y, Kitao A, Kurata K, Kakiuchi S, Miyata Y, Sanada Y, Kitagawa K, Uryu K, Kawamoto S, Yamamoto K, Matsuoka H, Murayama T, Ito M, Minami H.

Transpl Infect Dis. 2019 Feb;21(1):e13024. doi: 10.1111/tid.13024. Epub 2018 Nov 27.

PMID:
30414316
39.

Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.

Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M; Japan Study Group for Cell Therapy and Transplantation (JSCT).

Int J Hematol. 2019 Jan;109(1):131. doi: 10.1007/s12185-018-2557-5.

PMID:
30406327
40.

Surfactant-driven Amphoteric Doping of Carbon Nanotubes.

Nonoguchi Y, Tani A, Murayama T, Uchida H, Kawai T.

Chem Asian J. 2018 Dec 18;13(24):3942-3946. doi: 10.1002/asia.201801490. Epub 2018 Nov 15.

PMID:
30358121
41.

Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes.

Kutoh E, Wada A, Murayama T, Hayashi J.

Drugs R D. 2018 Dec;18(4):309-315. doi: 10.1007/s40268-018-0250-z.

42.

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.

Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M; Japan Study Group for Cell Therapy and Transplantation (JSCT).

Int J Hematol. 2019 Jan;109(1):107-114. doi: 10.1007/s12185-018-2543-y. Epub 2018 Oct 4. Erratum in: Int J Hematol. 2018 Nov 7;:.

PMID:
30284685
43.

A tryptophan residue in the caffeine-binding site of the ryanodine receptor regulates Ca2+ sensitivity.

Murayama T, Ogawa H, Kurebayashi N, Ohno S, Horie M, Sakurai T.

Commun Biol. 2018 Jul 23;1:98. doi: 10.1038/s42003-018-0103-x. eCollection 2018.

44.

A zeolitic vanadotungstate family with structural diversity and ultrahigh porosity for catalysis.

Zhang Z, Zhu Q, Sadakane M, Murayama T, Hiyoshi N, Yamamoto A, Hata S, Yoshida H, Ishikawa S, Hara M, Ueda W.

Nat Commun. 2018 Sep 17;9(1):3789. doi: 10.1038/s41467-018-06274-2.

45.

Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.

Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, Asaoku H, Cho T, Handa H, Hagiwara S, Wakayama T, Negoro A, Takezako N, Harada N, Kuroda Y, Nakaseko C, Miyake T, Inoue N, Hata H, Shimazaki C, Ohno T, Kuroda J, Murayama T, Kobayashi T, Abe M, Ishida T, Nagura E, Shimizu K.

Hematol Oncol. 2018 Dec;36(5):792-800. doi: 10.1002/hon.2559. Epub 2018 Sep 19.

PMID:
30176173
46.

Development of a new doubly-labeled fluorescent ceramide probe for monitoring the metabolism of sphingolipids in living cells.

Wang Y, Kasahara J, Yamagata K, Nakamura H, Murayama T, Suzuki N, Nishida A.

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3222-3226. doi: 10.1016/j.bmcl.2018.08.013. Epub 2018 Aug 15.

PMID:
30149971
47.

Influenza vaccine showed a good preventive effect against influenza-associated hospitalization among elderly patients, during the 2016/17 season in Japan.

Seki Y, Onose A, Murayama T, Koide C, Sugaya N.

J Infect Chemother. 2018 Nov;24(11):873-880. doi: 10.1016/j.jiac.2018.07.013. Epub 2018 Aug 9.

PMID:
30100400
48.

The challenges of characterising nanoparticulate catalysts: general discussion.

Arrigo R, Badmus K, Baletto F, Boeije M, Bowker M, Brinkert K, Bugaev A, Bukhtiyarov V, Carosso M, Catlow R, Chanerika R, Davies PR, Dononelli W, Freund HJ, Friend C, Gallarati S, Gates B, Genest A, Gibson EK, Hargreaves J, Helveg S, Huang H, Hutchings G, Irvine N, Johnston R, Lai S, Lamberti C, Macginley J, Marchant D, Murayama T, Nome R, Odarchenko Y, Quinson J, Rogers S, Russell A, Said S, Sermon P, Shah P, Simoncelli S, Soulantica K, Spolaore F, Tooze B, Torrente-Murciano L, Trunschke A, Willock D, Zhang J.

Faraday Discuss. 2018 Sep 3;208(0):339-394. doi: 10.1039/c8fd90014k. No abstract available.

PMID:
30095830
49.

Control of catalytic nanoparticle synthesis: general discussion.

Adishev A, Arrigo R, Baletto F, Bordet A, Bukhtiyarov V, Carosso M, Catlow R, Conway M, Davies J, Davies P, De Masi D, Demirci C, Edwards JK, Friend C, Gallarati S, Hargreaves J, Huang H, Hutchings G, Lai S, Lamberti C, Macino M, Marchant D, Murayama T, Odarchenko Y, Peron J, Prati L, Quinson J, Richards N, Rogers S, Russell A, Selvam P, Shah P, Shozi M, Skylaris CK, Soulantica K, Spolaore F, Tooze B, Torrente-Murciano L, Trunschke A, Venezia B, Walker J, Whiston K.

Faraday Discuss. 2018 Sep 3;208(0):471-495. doi: 10.1039/c8fd90015a. No abstract available.

PMID:
30091432
50.

Pulmonary extranodal marginal zone lymphoma that presented with macroglobulinemia and marked plasmacytic cell proliferation carrying the t(14;18)(q32;q21)/MALT1-immunoglobulin heavy-chain fusion gene in pleural fluid.

Akasaka T, Kishimori C, Maekawa F, Takeoka K, Hayashida M, Gomyo H, Murayama T, Ohno H.

J Clin Exp Hematop. 2018 Sep 19;58(3):141-147. doi: 10.3960/jslrt.18013. Epub 2018 Aug 8.

Supplemental Content

Loading ...
Support Center